Certainly not impossible... culled from Friday's Nightly Business Report...
"Market Monitor'-Dr. Hans Black, Chairman of Interinvest Friday, August 03, 2007
KANGAS: How about some new recommendations, even in this kind of market atmosphere it doesn't lend to many.
BLACK: We manage portfolios for clients, Paul, and we're looking for sectors and there are always sectors that we find attractive. Particularly we like the biotech sector and the pharma sector. We think that they're undervalued. We think there's a lot of growth, a lot of good news, a lot of takeovers happening in that sector. I'll mention Incyte (INCY), which is a company that trades from $500 million market cap, trades around $5 a share. Good deal with Pfizer and I'll mention another large pharma --.
KANGAS: Wait a minute. INCY is the symbol on NASDAQ on Incyte, right?
BLACK: That's correct.
KANGAS: OK and then number two?
BLACK: Bristol-Myers (BMY), which is another large pharma, a well-run company, had some problems but I think they're probably over the worst of them.
KANGAS: A recommendation from a medical doctor like yourself carries a little extra weight, I must say.